Biomarkers are objective indicators used to assess normal or pathological processes,
evaluate responses to treatment and predict outcomes. Many blood biomarkers already …

Fast and accurate diagnosis of stroke is crucial for the immediate application of the right
therapy to patients. However, rapid diagnosis is still a challenge since an ischemic stroke …

Stroke remains a leading cause of death worldwide and the first cause of disability in the
western world. Ischemic stroke (IS) accounts for almost 80% of the total cases of strokes and …

Around 15 years have now elapsed since thrombolysis was first shown to be effective for
treating acute ischemic stroke, but therapeutic uptake has been modest. As outlined in this …

Acute ischemic stroke (AIS), is the second global cause of death after cardiovascular
diseases, accounts for 80–85% of cerebrovascular disease. Stroke diagnosis could be …

Background and Purpose—Numerous studies have shown that circulating microRNAs
(miRNAs) can be used as noninvasive biomarkers of various diseases. This study aimed to …

OBJECTIVE: To evaluate whether concentrations of inflammation-related proteins are
elevated in the blood of preterm newborns who develop cerebral white matter damage …

The development of a clinically validated biomarker of acute cerebral ischemia would have
the potential to facilitate the use of time‐sensitive reperfusion strategies, allow for …

Aim: This systematic review provides a summary of the blood protein biomarkers that have
been studied for the diagnosis of acute ischemic stroke. Materials & methods: An extensive …

BACKGROUND: To evaluate if concentrations of inflammation-related proteins were
elevated in early postnatal blood specimens of preterm newborns who two years later had a …